Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 54

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 54
---
 more time-consuming and costly. After Living Homeopathy is no longer an “emerging growth company,” or until five years following the completion of Living Homeopathy’s initial public offering, whichever is earlier, Living Homeopathy expects to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 and the other rules and regulations of the SEC. For example, as a public company, Living Homeopathy has been required to increase the number of independent directors and adopt policies regarding internal controls and disclosure controls and procedures. Living Homeopathy has incurred additional costs in obtaining director and officer liability insurance. In addition, Living Homeopathy incurs additional costs associated with its public company reporting requirements. It may also be more difficult for Living Homeopathy to find qualified persons to serve on its board of directors or as executive officers. Living Homeopathy is currently evaluating and monitoring developments with respect to these rules and regulations, and Living Homeopathy cannot predict or estimate with any degree of certainty the amount of additional costs we may incur or the timing of such costs.

Living Homeopathy’s board of directors may decline to register transfers of Class A Ordinary Shares in certain circumstances.

Except in connection with the settlement of trades, transactions or transfers of Class A Ordinary Shares entered into through the facilities of a stock exchange or automated quotation system on which our Class A Ordinary Shares are listed or traded from time to time, Living Homeopathy’s Board may, in its sole discretion, decline to register any transfer of any Class A Ordinary Share.

If Living Homeopathy’s directors refuse to register a transfer they shall, within one month after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal. The registration of transfers may, after compliance with any notice required in accordance with the rules of the relevant stock exchange, be suspended and Living Homeopathy’s register of members closed at such times and for such periods as Living Homeopathy’s board of directors may from time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register closed for more than 30 days in any year.

This, however, is unlikely to affect market transactions of the Class A Ordinary Shares purchased by investors in the public offering. Once the Class A Ordinary Shares have been listed on the Nasdaq Capital Market, the legal title to such Class A Ordinary Shares and the registration details of those Class A Ordinary Shares in Living Homeopathy’s register of members will remain with Depository Trust Company (“ DTC”)/Cede & Co